149 related articles for article (PubMed ID: 14981930)
1. Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.
Shnyder SD; Cooper PA; Gyselinck N; Hill BT; Double JA; Bibby MC
Anticancer Res; 2003; 23(6C):4815-20. PubMed ID: 14981930
[TBL] [Abstract][Full Text] [Related]
2. Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.
Shnyder SD; Cooper PA; Pettit GR; Lippert JW; Bibby MC
Anticancer Res; 2003; 23(2B):1619-23. PubMed ID: 12820431
[TBL] [Abstract][Full Text] [Related]
3. Sequence-dependent activity of 5-fluorouracil plus tauromustine in a transplantable well-differentiated murine colon adenocarcinoma.
Hill SR; Pollard LA; Bibby MC
Anticancer Res; 1992; 12(6B):2169-75. PubMed ID: 1295464
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development.
Kruczynski A; Poli M; Dossi R; Chazottes E; Berrichon G; Ricome C; Giavazzi R; Hill BT; Taraboletti G
Eur J Cancer; 2006 Nov; 42(16):2821-32. PubMed ID: 16973349
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with combretastatin A-4 phosphate and 5-fluorouracil in an experimental murine colon adenocarcinoma.
Grosios K; Loadman PM; Swaine DJ; Pettit GR; Bibby MC
Anticancer Res; 2000; 20(1A):229-33. PubMed ID: 10769660
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model.
Holwell SE; Hill BT; Bibby MC
Br J Cancer; 2001 Jan; 84(2):290-5. PubMed ID: 11161390
[TBL] [Abstract][Full Text] [Related]
8. Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.
Kruczynski A; Hill BT
Crit Rev Oncol Hematol; 2001 Nov; 40(2):159-73. PubMed ID: 11682323
[TBL] [Abstract][Full Text] [Related]
9. Effects of short term treatment with pentagastrin, proglumide, tamoxifen given separately or together with 5-fluorouracil on the growth in the murine transplantable Colon 38 cancer.
Mełeń-Mucha G
Neoplasma; 2001; 48(2):133-8. PubMed ID: 11478694
[TBL] [Abstract][Full Text] [Related]
10. Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs.
Wynter MP; Russell ST; Tisdale MJ
In Vivo; 2004; 18(5):543-7. PubMed ID: 15523890
[TBL] [Abstract][Full Text] [Related]
11. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
[TBL] [Abstract][Full Text] [Related]
12. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Saif MW; von Borstel R
Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of murine colorectal carcinoma with cisplatin and cisplatin plus 3'-deoxy-3'-azidothymidine.
Klann RC; Holbrook CT; Nyce JW
Anticancer Res; 1992; 12(3):781-7. PubMed ID: 1535769
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
15. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J;
Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886
[TBL] [Abstract][Full Text] [Related]
16. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
[TBL] [Abstract][Full Text] [Related]
18. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
Drago JR; Smith J
In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside analogues. 5. Molecular combination of anti-cancer drugs: activity of 5-fluorouracil/nitrosourea combinations against mouse colon tumours.
Double JA; Bibby MC; McCormick JE; McElhinney RS
Anticancer Drug Des; 1986 Apr; 1(2):133-9. PubMed ID: 3450289
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]